<DOC>
	<DOCNO>NCT00162071</DOCNO>
	<brief_summary>The primary purpose study determine optimal time myocardial perfusion image Technetium Tc99m Sestamibi follow administration BMS068645 . The safety BMS068645 also study .</brief_summary>
	<brief_title>A Phase II Optimization Study BMS068645 Sestamibi Planar Imaging</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>18 year age old Have know suspect heart disease Have undergone clinically indicate SPECT MPI study adenosine last 24 hour 14 day . Weigh 88 250 lb . Allergic reaction Technetium Tc99m Sestamibi component History asthma lung disease Ingestion caffeinated substance within 12 hour prior study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>